molecular landscape
Showing 1 - 25 of 5,208
Clinical Implications for NSCLC Patients With Rare Mutations
Recruiting
- NSCLC
- +2 more
-
Shanghai, Shanghai, China
- +1 more
Jan 18, 2023
Molecular Analysis and Treatment Options of SCLC
Recruiting
- Small-cell Lung Cancer
- +4 more
-
Shanghai, ChinaShanghai Chest Hospital
Jul 6, 2023
Molecular Analysis and Treatment Options of Thymic Malignancies
Recruiting
- Thymic Epithelial Tumor
- +2 more
-
Shanghai, Shanghai, ChinaXiaomin Niu
Dec 28, 2022
Decoding the Genetic Landscape of Skeletal Diseases
Recruiting
- Genetic Skeletal Diseases
- +3 more
-
Stockholm, SwedenKarolinska University Hospital
May 16, 2023
Breast Cancer After Ovarian Cancer During and/or After Therapy:
Recruiting
- BRCA-Associated Breast Carcinoma
- Next-generation sequencing (NGS) assay TruSight Oncology 500 (TSO 500).
-
Rome, RM, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Mar 9, 2023
Cellular Landscape of Hip Osteoarthritis
Recruiting
- Osteoarthritis, Hip
- Rheumatoid Arthritis
- Total hip arthroplasty
-
Espoo, Uusimaa, Finland
- +3 more
Nov 1, 2022
Drug Resistance in Immune Checkpoint Inhibitors of Non-small
Recruiting
- Non-Small Cell Lung Cancer
- Anti-PD-1/PD-L1 monoclonal antibody
-
Shanghai, Shanghai, ChinaXiaomin Niu
Jul 24, 2021
Endometrial Cancer in Brazil
Not yet recruiting
- Endometrial Cancer
- Observational study
- (no location specified)
Aug 23, 2023
According to Molecular Identification at Diagnosis
Not yet recruiting
- Chronic Myeloid Leukemia
- Next Generation Sequencing (DNA and RNA)
- (no location specified)
Oct 28, 2022
Lung Cancer Using Noninvasive Biomarkers
Recruiting
- Pulmonary Nodules
- A genomic and transcriptomic landscape analysis
-
Beijing, China
- +5 more
Feb 15, 2022
Breast Cancer, Prostate Cancer Trial in Philadelphia (Standard of Care)
Recruiting
- Breast Cancer
- Prostate Cancer
- Standard of Care
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Feb 22, 2023
Gastric Cancer, Signet Ring Cell Carcinoma Trial in Hangzhou (Without any intervention)
Active, not recruiting
- Gastric Cancer
- Signet Ring Cell Carcinoma
- Without any intervention
-
Hangzhou, Zhejiang, ChinaCancer Hospital of the University of Chinese Academy of Sciences
Aug 2, 2023
Early Development of Endometrial Carcinoma
Recruiting
- Cancer of Endometrium
-
Ferrara, ItalySection of Obstetrics and Gynecology, Department of Morphology,
Apr 4, 2022
Oncogenetic Panel and Integrated Clinical Data Registry Study
Recruiting
- Gastrointestinal Stromal Tumor (GIST)
-
Changhua, Taiwan
- +12 more
Dec 6, 2022
Uterine Cervical Tumors Trial in São Paulo
Recruiting
- Uterine Cervical Neoplasms
-
São Paulo, BrazilA Real e Benemérita Associação Portuguesa de Beneficência
Nov 28, 2022
A Taiwanese Oncogenetic Panel and Integrated Clinical Data
Recruiting
- Thyroid Cancer
- A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Advanced Thyroid Cancer Patients
-
Kaohsiung, Taiwan
- +7 more
Sep 12, 2022
NSCLC Trial in Worldwide (Sasanlimab Prefilled syringe, Encorafenib, Binimetinib)
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- Sasanlimab Prefilled syringe
- +5 more
-
Duarte, California
- +96 more
Jan 18, 2023
Liquid Biopsy to Enable Diagnostics and Monitoring for
Recruiting
- Lymphoproliferative Disorders
- Lymphoproliferative Disorder Following Transplantation
- Liquid biopsy
-
Basel, Switzerland
- +5 more
Mar 24, 2023
Non Small Cell Lung Cancer Trial in Brussels (FAPI PET/CT)
Recruiting
- Non Small Cell Lung Cancer
- FAPI PET/CT
-
Brussels, BelgiumInstitut Jules Bordet
Oct 24, 2023
Targeted Pediatric High-Grade Glioma Therapy
Not yet recruiting
- High Grade Glioma
- +8 more
-
Aurora, Colorado
- +17 more
May 1, 2023
Detect and Expunge Concealed Tumors of the Liver
Recruiting
- Liver Cancer
-
Hanoi, Vietnam108 Military Central Hospital
Nov 15, 2023
Lung Cancer Trial in Vienna
Recruiting
- Lung Cancer
-
Vienna, AustriaKarl Landsteiner Institut für Lungenforschung und Pneumologische
Aug 17, 2022
Sebaceous Cell Tumor of Eyelid Trial in Roma (exome sequencing (retrospective) and exome and methylome sequencing (prospective))
Recruiting
- Sebaceous Cell Tumor of Eyelid
- exome sequencing (retrospective) and exome and methylome sequencing (prospective)
-
Roma, Rome, ItalyGustavo Savino
Oct 8, 2023
Digital Support of Patients With Inoperable Lung Cancer
Recruiting
- Non-Small Cell Carcinoma of Lung, TNM Stage 4
- Digital platform
-
Psychikó, Attiki, Greece
- +14 more
May 12, 2022